Zur Startseite Zur Hauptnavigation Zum Inhalt Zum Kontakt Zur Sitemap
+A-
ENDE
  menu
Center for Sepsis Control and Care
  EMERGENCY
  menu
  • Sepsis
  • Research
    • Publications
    • Archive 2015-2020
    • Archive 2010-2015
      • Risk Assessment and Sepsis Control
      • Novel Diagnostic Tools and Approaches
      • Acute Care
      • Sepsis-related Organ Failure
        • PRAISE
        • HHDP
        • HIFMORG
        • SMAD2
        • Candida
        • SomatostatinR
        • PI3Kgamma
        • Rosisep
        • ADAMTS13
        • Thrombomodulin
        • Liver Dysfunction
        • Seda
        • Sephi
        • Phosphatidylcholine
        • MomCanSep
      • Long-term Sequelae
      • Overarching Projects
  • World Sepsis Day
  • Main menu
    • Patients & Relatives
    • Research
    • Teaching and study
    • Doctors & Referrers
    • Clinics & Institutes
    • Careers
    • University Hospital
  • Sepsis
  • Research
    • Publications
    • Archive 2015-2020
    • Archive 2010-2015
      • Risk Assessment and Sepsis Control
      • Novel Diagnostic Tools and Approaches
      • Acute Care
      • Sepsis-related Organ Failure
        • PRAISE
        • HHDP
        • HIFMORG
        • SMAD2
        • Candida
        • SomatostatinR
        • PI3Kgamma
        • Rosisep
        • ADAMTS13
        • Thrombomodulin
        • Liver Dysfunction
        • Seda
        • Sephi
        • Phosphatidylcholine
        • MomCanSep
      • Long-term Sequelae
      • Overarching Projects
  • World Sepsis Day
home / Research / Archive 2010-2015 / Sepsis-related Organ Failure / SMAD2

Analysis of the mechanisms of chronification in a sepsis model in a cell- or organ-specific smad2 K.O. mouse

 

Acronym: SMAD2

Principal Investigator: Dr. rer. nat. Elke Kunisch 

Team: Prof. Dr. med. Raimund W. Kinne

research Area: D Sepsis related Organ Failure

Project Number: D1.4

Duration: 01.08.2010 - 31.07.2012

Module: Rotational Position


The Problem

Currently, nearly nothing is known about organ failure as long-term sequelae of sepsis. The project aims at characterizing the molecular mechanisms of long-term sequelae in a mouse model of sepsis.


Results obtained during the funding period

In collaboration with the CSCC, the Department of Anestesiology and the Institute of Pathology (Jena University Hospital), a long-term murine model of sepsis has been described by our group. The model showed a survival rate of approx. 40%. Whereas clinical severity score, food-intake, and body weight normalized until day 6, 4-week survivors still had an elevated white blood cell and platelet count, as well as elevated levels of markers for liver injury. In the liver of the mice, inflammatory infiltrates and substantial fibrosis was observed. Increased numbers of potentially pathogenetic macrophages and α-SMA-positive cells were detected in the vicinity of fibrotic areas. Together with augmented TGF-ß mRNA expression, increased phosphorylation of its signalling molecule Smad2 was seen. In order to address the role of the pro-fibrotic TGF-ß signalling for organ-fibrosis in sepsis, a fibroblast-specific Smad2 k.o. mouse was established. Initial short-time sepsis trials showed a higher survival rate in fibroblast-specific Smad2 k.o. mice (100%) than in wild-type mice 24 h after sepsis-induction (63%).


Publications

Gonnert FA, Kunisch E, Gajda M, Lambeck S, Weber M, Claus RA, Bauer M, Kinne RW: Hepatic Fibrosis in a Long-Term Murine Model of Sepsis. Shock 2012 Apr, 37(4):399-407


Contact 

Prof. Dr. med. Raimund W. Kinne

Tel.: +49 (0)36691 - 81 228

Universitätsklinikum Jena
Lehrstuhl für Orthopädie
AG Experimentelle Rheumatologie
Klosterlausnitzer Str. 81
07607 Eisenberg

Sepsis
Research
World Sepsis Day
Sitemap